Skip to main content
. 2020 Mar 4;9(3):689. doi: 10.3390/jcm9030689

Table 1.

General characteristics of the patients.

Variables Value
Age (years) 62.5 ± 9.5
Sex
Female 113 (39.4)
Male 174 (60.6)
Past history
No 75 (26.1)
Yes 212 (73.9)
Symptoms
No 57 (19.9)
Yes 230 (80.1)
Complications (Clavien-Dindo Classification)
None 135 (47.0)
Grade 1 98 (34.1)
Grade 2 17 (5.9)
Grade 3 24 (8.4)
Grade 4 10 (3.5)
Grade 5 3 (1.0)
T status
T0, T1, T2 262 (91.3)
T3, T4 25 (8.7)
N status
N0 137 (47.7)
N1, N2 150 (52.3)
Preoperative CA19_9 719.6 ± 202.7
Neo CRT (Neoadjuvant chemoradiation therapy)
No 206 (71.8)
Yes 81 (28.2)
Adj. CTx (Adjuvant chemotherapy)
No 76 (26.5)
Yes 211 (73.5)
Tumor location
Head 111 (38.7)
Uncinate 66 (23.0)
Neck 6 (2.1)
Body 63 (22.0)
Tail 35 (12.2)
Body + tail 6 (2.1)
LVI (Lymphovascular invasion)
No 198 (69.0)
Yes 89 (31.0)
PNI (Perineural invasion)
No 106 (36.9)
Yes 181 (63.1)
Resectability
Resectable 215 (74.9)
Borderline 72 (25.1)
Surgery type
PD 17 (5.9)
PPPD 162 (56.4)
DP 101 (35.2)
TP 7 (2.4)
Operation time (min) 392.6 ± 148.5
Combined resection
No 194 (67.6)
Yes 93 (32.4)
Curative resection
R0 249 (86.8)
R1 34 (11.8)
R2 4 (1.4)
EBL (mL) 654.8 ± 215.5
IOT
No 218 (76.0)
Yes 69 (24.0)

Notes: All data are expressed as mean ± SD or N (%) Abbreviations: PD, pancreatoduodenectomy; PPPD. Pylorus preserving pancreatoduodenectomy; DP, distal pancreatectomy; TP, Total pancreatectomy; Neo CRT, Neoadjuvant chemoradiation therapy; Adj. CTx, Adjuvant chemotherapy; LVI, Lymphovascular invasion; PNI, Perineural invasion; IOT, intraoperative transfusion; and EBL, Estimated blood loss.